ESSEX BIO-TECHNOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 1061 for the last semiannual is 807.20 M HKD, and it's 10.25% lower compared to the previous semiannual. The net income of H2 23 is 105.45 M HKD.